Abstract Despite remarkable advances in cancer drug treatment, including chemotherapy, targeted therapy, and immunotherapy, therapeutic resistance remains a formidable clinical barrier, limiting durable responses and long-term survival
& Malchow, B
Figure 1: Obesity rates on the rise in the US Why
Clinical Classification of Chronic Venous Disease C0: No visible or palpable sign of venous disease C1: Spider veins or reticular veins (veins that feed spider veins) C2: Varicose veins C3: Edema (swelling) C4: Changes in skin and tissues A: Pigmentation or eczema B: Thickening, hardening, swelling, redness, inflammation, scarring C5: Healed venous ulcer C6: Active venous ulcer Note: Some potential complications of venous disease, such as DVT, can occur even in people who have no overt signs
(2010) proved this in a rat MCL transection model
Nanozymes, nanomaterials with enzymatic activities, have garnered considerable interest for treating IMIDs due to their potential to counteract oxidative stress